Limited Time Offer
Get $1000 towards your
first investment
Start investing in private markets with Linqto – your access to disruptive startups and pre-IPO companies.
*Terms and conditions apply. See details
Shukun Technology, founded in 2017 and headquartered in Beijing, China, is a leading provider in the smart medical and health technology platform sector. The company specializes in artificial intelligence-powered diagnostic assistance products covering various diseases across multiple body parts. Shukun Technology's comprehensive solutions encompass medical imaging, surgical planning, and health management, leveraging multi-modality technology and original research to serve the healthcare industry.
Since its inception, Shukun Technology has demonstrated significant growth and attracted substantial investor interest. The company has successfully completed multiple funding rounds, including a Series D round in August 2021 that raised over $108 million and valued the company at approximately $1.46 billion. Notable investors include Goldman Sachs Asset Management, HongShan, and Primavera Capital Group, among others.
As of now, there is no official information or confirmed reports regarding Shukun Technology's IPO prospects. The company has not made any public announcements about plans to go public, and we have not found any credible news sources discussing potential IPO timelines or preparations.
Several factors could influence Shukun Technology's decision to pursue an IPO in the future, including market conditions, the company's financial performance, and its strategic growth plans. The healthcare software industry, particularly in the AI-driven diagnostic sector, continues to attract significant attention from investors. However, it's important to note that any discussion about a potential Shukun Technology IPO remains speculative at this time.
Investors interested in Shukun Technology should continue to monitor official company announcements and reputable financial news sources for any updates regarding the company's funding status or potential plans to go public. As always, it's advisable to conduct thorough research and consider various factors before making any investment decisions.
Get $1000 towards your
first investment
*Terms and conditions apply. See details
While Shukun Technology's IPO prospects remain uncertain, investors eager to explore opportunities in the AI-driven healthcare technology space don't have to wait. At Linqto, we offer members access to interests in promising private companies before they go public. Our platform provides the opportunity to invest in potential leaders in the healthcare tech sector, like Shukun Technology, with lower minimum investments than traditional private equity opportunities. This allows you to potentially benefit from their growth and innovation before they hit the public markets.
*These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO. The information provided above is based on current online discussions and is not intended as investment advice. Linqto does not endorse or guarantee the accuracy of this information, and we strongly recommend conducting your own research or consulting with a professional advisor before making any investment decisions. Linqto cannot be held liable for any investment outcomes resulting from the use of this information.
